760150 Webinar Innovation Management And Technology Transfer In China

Innovation Management and Technology Transfer in China: The Big Picture And The Little Details July 22, 2010

Presenters Panelist Guang Yang, Ph.D. Associate Director Platform Technology, GlaxoSmithKline(China)R&D Co., Ltd. Shanghai, P.R. China Panelist Greg B. Scott Founder and President, ChinaBio® LLC Shanghai, P.R. China San Diego, California Panelist James C. Chapman Partner, Foley & Lardner LLP Silicon Valley, California Moderator James F. Ewing Partner, Foley & Lardner LLP Vice Chair, Chemical, Biotechnology & Pharmaceutical Practice Boston, Massachusetts

Science-Technology Development Guidelines (2006-2020) ,[object Object],[object Object],[object Object],[object Object],[object Object]

The Five-Year Plan for National Economic and Social Development ,[object Object],[object Object],[object Object],[object Object]

Major High-tech Projects (2006-2010) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Agenda ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Realities of Commercializing Technology in China

Commercialization of New Technology in China ,[object Object],[object Object],[object Object]

Mega New Drug Development Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: ChinaBio ® Consulting

Commercialization of New Technology in China (cont.) ,[object Object],[object Object],[object Object],[object Object]

Technology Categories (Import and Export) ,[object Object],[object Object],[object Object]

Chinese Government Approval ,[object Object],[object Object],[object Object],[object Object],[object Object]

Barriers to Entry for Foreign Individuals/Entities ,[object Object],[object Object],[object Object],[object Object]

Where in China is Technology Being Developed?

Innovation Centers ,[object Object],Beijing Cluster Shanghai Cluster Central Cluster Southern Cluster Source: ChinaBio ® Consulting

Patents by Location ,[object Object],* 20% of patents from 27 other provinces Source: ChinaBio ® Consulting, SIPO

Restrictions on Foreign Investment ,[object Object],[object Object]

Recommended Strategies ,[object Object],[object Object]

Life Science Technology Development in China

Life Science Technology Development in China Guang Yang

GSK R&D China: September 2007 – Late-stage Development EDU Early-stage Development PCD DMPK BD TIP research Compound screen Assay Dev. Biology Chemistry Operations R&D Capabilities We are here… Time Neurology R&D (Global Pipeline) Neurodegeneration Neuroinflammation 40 staff 250 staff 330 staff 170 staff 120 staff 1 st employee 4,000 M 2 new research facility 2 nd building 3,000 M 2 office and lab facility Singapore site joined R&D China July 2008 3 DPUs 420 staff Late-stage development ,[object Object],[object Object],[object Object],[object Object],9-2007 2008 2009 2010 China Medicines Development (China Pipeline) Cross-therapeutic areas

Emerging Rx Market Growing at 19% Annually 3 rd Largest Pharmaceutical Market in 2015 Note: 1. Source: IMS World Review 2007 2. Source: IMS Market Prognosis 2007-2011 3. At ex-manufacturer price level Rank 2002 1 (USD Bn) 2004 1 (USD Bn) 2006 2 (USD Bn) 2008 2 (USD Bn) 2010 2 (USD Bn) 2011 2 (USD Bn) 1 USA 198 USA 241 USA 275 USA 309 USA 356 United States 379 2 Japan 53 Japan 65 Japan 63 Japan 67 Japan 72 Japan 75 3 France 20 France 30 France 35 France 37 France 40 Germany 42 4 Germany 20 Germany 29 Germany 33 Germany 36 Germany 40 France 42 5 UK 14 UK 20 Italy 21 UK 24 UK 27 UK 29 6 Italy 13 Italy 19 UK 21 Italy 22 Italy 24 China 26 7 Spain 9 Spain 13 Spain 16 Canada 18 China 23 Italy 26 8 Mexico 8 Canada 12 Canada 15 China 18 Canada 21 Canada 22 9 Canada 8 China 10 China 14 Spain 17 Spain 19 Spain 19 10 China 6 Mexico 8 Brazil 11 Brazil 13 Brazil 15 Brazil 17 11 Brazil 5 Brazil 7 Mexico 11 Mexico 12 Mexico 14 Russian Fed. 16 12 South Korea 5 Australia 6 South Korea 9 South Korea 11 Russian Fed. 14 Mexico 15 13 India 5 South Korea 6 Turkey 7 Russian Fed. 10 South Korea 13 South Korea 14 14 Australia 4 Turkey 6 India 7 India 9 India 12 India 14 15 Turkey 3 India 6 Australia 7 Turkey 9 Turkey 11 Turkey 12

Ageing Demographics Data sources: China Health Statistics, www.moh.gov.cn

China Health-care Reform ,[object Object],[object Object],Source: People’s Daily, April 7, 2009

Talent Pool and Life Science in China ,[object Object],[object Object],Neuroscience publications (Jan 04 – May 05) Source: PubMed ( Limited search to English language article published between Jan. 1, 2004 and May 31, 2005), WHO website Source: “High education system in China – An overview” 2006; China Education Yearbook 2001 - 2007 X 1000 X 1000

Life Science in China ,[object Object],[object Object],[object Object],[object Object]

China Life Science Greg B. Scott

China’s future: #1 in life science? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: ChinaBio ® Consulting, MOE

Driving Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: ChinaBio ® Consulting, MOE

Government Funding ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Source: ChinaBio ® Consulting

Government Funding (cont.) ,[object Object],[object Object],[object Object]

Novel Molecule Patents ,[object Object],Source: ChinaBio ® Consulting, SIPO

Institutional Funding ,[object Object],[object Object],[object Object],Source: ChinaBio ® Consulting

Sample Partnering Deals Source: ChinaBio ® Consulting Company A Company B Date Collaborate type Peking University Pfizer China * Q1 ‘09 Partnership Hutchison MediPharma * Ortho-McNeil-Janssen Pharmaceuticals, Inc. Q1 ‘09 Co-development Simcere Pharma Epitomics, Inc. Q1 ‘09 Co-development Lee’s Pharmaceutical Nippon Shinyaku Q1 ‘09 In-license Tianjin Tianda Pharmaceutical Co., Ltd. Simcere Pharmaceutical Group Q4 ‘09 Partnership BMP Sunstone Corporation Pfizer China* Q4 ‘09 Co-marketing Tianjin Tianda Pharmaceutical Co., Ltd. Simcere Pharmaceutical Group Q4 ‘09 Partnership Ascentage Pharma Group Corporation, Ltd.* 3SBio Inc. * Q1 ‘10 Co-development & Co-marketing Mindray Medical Pulsion Medical Systems Q2 ‘10 In-license Genzyme Corporation Tianjin (TJAB) * Q2 ‘10 Partnership

Due Diligence ,[object Object],[object Object],[object Object],[object Object]

Forms of Agreements ,[object Object],[object Object],[object Object]

Key Issues in Technology Transfer Agreements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],PRC Requirements

PRC Requirements (cont.) ,[object Object],[object Object],[object Object],[object Object],[object Object]

Strategies to Mitigate/Avoid Disputes

Best Practices to Avoid a Dispute ,[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],Dispute Resolution

Arbitration in China ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],Guang Yang Greg B. Scott James C. Chapman James F. Ewing

Contact Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

760150 Webinar Innovation Management And Technology Transfer In China

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Andere mochten auch

Andere mochten auch (20)

Ähnlich wie 760150 Webinar Innovation Management And Technology Transfer In China

Ähnlich wie 760150 Webinar Innovation Management And Technology Transfer In China (20)

760150 Webinar Innovation Management And Technology Transfer In China